Pediatrix Medical (MD) Receivables Refunds (2009 - 2026)

Pediatrix Medical (MD) has 8 years of Receivables Refunds data on file, last reported at $12.2 million in Q1 2026.

• Quarterly Receivables Refunds rose 18.65% year-over-year to $12.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.2 million (up 18.65% YoY) and the FY2025 annual result came in at $12.6 million, changed 0.21% from the prior year.
• Receivables Refunds slipped to $12.2 million in Q1 2026 per MD's latest filing, from $12.6 million in the prior quarter.
• Across five years, Receivables Refunds topped out at $21.5 million in Q2 2022 and bottomed at $1.2 million in Q3 2024.
• The 5-year median for Receivables Refunds is $9.7 million (2022), against an average of $9.5 million.
• The widest annual swing landed in 2022, when Receivables Refunds tumbled 43.7%; it then soared 218.45% in 2025.
• Tracing MD's Receivables Refunds over 5 years: stood at $9.7 million in 2022, then declined by 22.24% to $7.6 million in 2023, then soared by 66.74% to $12.6 million in 2024, then increased by 0.21% to $12.6 million in 2025, then slipped by 3.58% to $12.2 million in 2026.
• Per Business Quant, the three latest MD Receivables Refunds figures stand at $12.2 million (Q1 2026), $12.6 million (Q4 2025), and $3.8 million (Q3 2025).

Peer Comparison